TickerFacts.

Compare

Organogenesis Holdings Inc. vs HUTCHMED (China) Ltd vs Opko Health, Inc. vs Mirum Pharmaceuticals, Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearOrganogenesis Holdings Inc.
ORGO		HUTCHMED (China) Ltd
HCM		Opko Health, Inc.
OPK		Mirum Pharmaceuticals, Inc.
MIRM
Year ended2025-12-312025-12-312025-12-312025-12-31
Revenue$564.17M$548.51M$606.88M$521.31M
Revenue growth (YoY)+17.0%-13.0%-14.9%+54.7%
Gross marginn/a38.7% (computed)33.9%n/a
Operating margin7.9%-7.1%-19.3%-4.2%
Net margin6.6%83.3%-37.2%-4.5%
Net income$37.03M$456.91M-$225.68M-$23.36M
EPS (Diluted)$0.15$0.52-$0.30-$0.47
Operating cash flow-$10.31M-$64.66M-$178.54M$55.83M
Free cash flow-$24.46M-$78.81M-$190.82M$54.87M
Cash & equivalents$93.68M$71.33M$364.41M$296.68M
Total assets$598.73M$1.75B$1.93B$842.81M
Total liabilities$164.81M$501.83M$663.99M$528.12M
Shareholders' equity$300.13M$1.25B$1.27B$314.69M
Return on year-end equity12.3%36.5%-17.8%-7.4%
Shares outstanding126.95Mn/an/a51.90M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearOrganogenesis Holdings Inc.HUTCHMED (China) LtdOpko Health, Inc.Mirum Pharmaceuticals, Inc.
Latest$564.17M
Ended 2025-12-31		$548.51M
Ended 2025-12-31		$606.88M
Ended 2025-12-31		$521.31M
Ended 2025-12-31
1 year earlier$482.04M
Ended 2024-12-31		$630.20M
Ended 2024-12-31		$713.14M
Ended 2024-12-31		$336.89M
Ended 2024-12-31
2 years earlier$433.14M
Ended 2023-12-31		$838.00M
Ended 2023-12-31		$863.50M
Ended 2023-12-31		$186.37M
Ended 2023-12-31
3 years earlier$450.89M
Ended 2022-12-31		$426.41M
Ended 2022-12-31		$1.00B
Ended 2022-12-31		$77.06M
Ended 2022-12-31
4 years earlier$467.36M
Ended 2021-12-31		$356.13M
Ended 2021-12-31		$1.77B
Ended 2021-12-31		$19.14M
Ended 2021-12-31